Save Share Educate #GLP1ReceptorAgonists #IncretinTherapy #DiabetesPharmacology #ClinicalPharmacy #Endocrinology #MedEd #Type2Diabetes #WeightLoss #ASCVD GLP-1 Receptor Agonists Improve Glycemic Control & Weight Loss GLP-1 Receptor Agonists | Incretin-Based Therapy GLP-1 receptor agonists are synthetic analogs of human GLP-1 that provide pharmacologic incretin effects, improving glycemic control while supporting weight loss and cardiovascular benefits
Doctors may prescribe GLP-1 medicines to help with: Type 2 diabetes control Weight management Appetite control Blood sugar improvement Cardiometabolic risk management in selected patients These drugs may also affect inflammation, blood vessels, and heart-related pathways
doi:10.2165/11898640-000000000-00000 Attar A, Lmann M, Ferguson A, et al
In todays world, exposure to toxins is unavoidable
Millions of people today deal with ongoing joint aches, stiffness, swelling, and unexplained fatigue linked to low-grade inflammation
Their small size renders them simpler to synthesize and modify
